Active bacterial core surveillance of the emerging infections program network.

By A. Schuchat, Tami M. Hilger, E. Zell, M. Farley, A. Reingold, L. Harrison, L. Lefkowitz, R. Danila, K. Stefonek, N. Barrett and 2 more. Emerging Infectious Diseases, 2001

757 citations recorded by the source corpus.

Active Bacterial Core surveillance (ABCs) is a collaboration between the Centers for Disease Control and Prevention and several state health departments and universities participating in the Emerging Infections Program Network. ABCs conducts population-based active surveillance, collects isolates, and performs studies of invasive disease caused by Streptococcus pneumoniae, group A and group B Streptococcus, Neisseria meningitidis, and Haemophilus influenzae for a population of 17 to 30 million. These pathogens caused an estimated 97,000 invasive cases, resulting in 10,000 deaths in the United States in 1998. Incidence rates of these pathogens are described. During 1998, 25% of invasive pneumococcal infections in ABCs areas were not susceptible to penicillin, and 13.3% were not susceptible to three classes of antibiotics. In 1998, early-onset group B streptococcal disease had declined by 65% over the previous 6 years. More information on ABCs is available at www.cdc.gov/ncidod/dbmd/abcs. ABCs specimens will soon be available to researchers through an archive.

Subfields: Epidemiology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/6872e4f1fde2751c37b4f8dd358a628f25c23e06

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

C. Phares
J. Mohle-Boetani
S. Petit
S. Zansky
K. Gershman
S. Schrag
Philip J. Smith
M. Moore

Citations in the corpus

Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology (2018, neutral): “In Europe and North America, CC398 is the most dominant LA-MRSA strain, although it has also been detected sporadically in Asia and Africa (64, 830–833).”
Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. (2010, methodology): “We identified IPD cases through Active Bacterial Core surveillance (ABCs), an active population- and laboratory-based system [5, 12].”
Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. (2008, methodology): “The ABCs methods have been described elsewhere.(20) Briefly, participating states conduct active, population-based, laboratory surveillance for invasive disease due to group B streptococcus and other pathogens.”